The diagnostic pathway to sarcoidosis

Marc A. Judson, Bruce W. Thompson, David L. Rabin, Joanne Steimel, Genell L. Knattereud, Daniel T. Lackland, Cecile Rose, Cynthia S. Rand, Robert P. Baughman, Alvin S. Teirstein

Research output: Contribution to journalArticlepeer-review

146 Scopus citations


Purpose: To examine the time from the first physician visit to the diagnosis of sarcoidosis. Hypotheses: The time required to diagnose sarcoidosis is dependent on the initial symptoms, socioeconomic status, referral to a specialist, race, and severity of pulmonary involvement. Methods: Patients were recruited from the Case Control Etiology of Sarcoidosis Study (ACCESS) and had biopsy-confirmed sarcoidosis. Subjects were asked to recall the date of onset of symptoms of sarcoidosis, their first physician visit, number of physician visits, and types of physicians seen. Results: One hundred eighty-nine patients were enrolled. The diagnosis of sarcoidosis was made on the first physician visit in only 15.3% of cases. The presence of pulmonary symptoms was associated with prolonged time (> 6 months vs ≤ 6 months, p = 0.02) until diagnosis, and the presence of skin symptoms with a shorter time (≤ 6 months vs > 6 months, p = 0.02) until diagnosis. Patients with pulmonary symptoms had more physician visits (mean ± SEM) until the diagnosis was made compared to those without pulmonary symptoms (4.84 ± 0.38 visits vs 3.15 ± 0.24 visits, p = 0.0002). The mean baseline FEV1 was greater in those diagnosed ≤ 6 months from the first physician visit than those diagnosed > 6 months (87.3 ± 1.52% predicted vs 81.2 ± 2.5% predicted, p = 0.04). There was a significant delay in diagnosis (> 6 months vs ≤ 6 months) from first physician visit with higher Scadding stages (stage 4 vs stage 2, or stage 3 vs stage 0 or 1, p = 0.04). Conclusions: The diagnosis of sarcoidosis is often delayed and seems to be more a factor of disease presentation than patient or physician characteristics. The presence of pulmonary symptoms or higher radiographic stages is associated with a prolonged time until diagnosis. The presence of skin symptoms is associated with less delay in diagnosis. It is likely that the delay in diagnosis of pulmonary sarcoidosis relates to the fact that pulmonary symptoms and parenchymal involvement are nonspecific and are often regarded as manifestations of other pulmonary diseases.

Original languageEnglish (US)
Pages (from-to)406-412
Number of pages7
Issue number2
StatePublished - Feb 1 2003


  • Diagnosis
  • Pulmonary
  • Sarcoidosis
  • Skin

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The diagnostic pathway to sarcoidosis'. Together they form a unique fingerprint.

Cite this